Professor Stephen Mahler is a Senior Group Leader at the Australian Institute for Bioengineering and Nanotechnology and Director of the Australian Research Council Training Centre for Biopharmaceutical Innovation (CBI), University of Queensland. Professor Mahler is a biotechnologist with a focus on R&D of recombinant-DNA derived protein biopharmaceuticals, drug delivery systems and nanomedicines. Professor Mahler has a record of translational research success and engages extensively with industry associated with the biomedical sciences both nationally and internationally.
Research within CBI covers three thematic research areas; discovery of new biopharmaceuticals, engineering cells for production of protein-based biopharmaceuticals and advanced manufacturing for industrial production. A current research interest is at the interface of the life sciences and materials science, using a synthetic biology approach for creating novel therapeutic entities as well as new systems for drug delivery.
Professor Mahler has a strong interest in education and training and was formerly Head of the Chemical and Biological Engineering Plan at the University of Queensland (2010-2016). Other educational initiatives include development of Masters Programs and a Continuing Professional Development program in the area of biopharmaceuticals. The CPD program is available to stakeholders in the industry, both in Australia and internationally.
Professor Mahler has a strong engagement with industry both nationally and internationally, that through collaborative research has led to some significant translational outcomes including clinical trial of biopharmaceutical drug candidates through to approval. The Australian Research Council Training Centre for Biopharmaceutical Innovation is a consortium of partners including government, the University of Queensland and several industry partners, with a goal of contributing to the transformation of the biopharmaceutical industry. Through the Centre and the CPD Program in Biopharmaceuticals, Professor Mahler continues to work with stakeholders to ensure a vibrant future for the biopharmaceutical industry in Australia.
Journal Article: Design of polarity-dependent immunosensors based on the structural analysis of engineered antibodies
Islam, Jiaul, Conroy, Paul, Fercher, Christian, Kim, Mijin, Yaari, Zvi, Jones, Martina, Bell, Toby D. M., Caradoc-Davies, Tom, Law, Ruby, Whisstock, James, Heller, Daniel, Mahler, Stephen and Corrie, Simon (2023). Design of polarity-dependent immunosensors based on the structural analysis of engineered antibodies. ACS Chemical Biology, 18 (8), 1863-1871. doi: 10.1021/acschembio.3c00303
Journal Article: Evaluation of phage display biopanning strategies for the selection of anti-cell surface receptor antibodies
Panagides, Nadya, Zacchi, Lucia F., Souza, Mitchell J. De, Morales, Rodrigo A. V., Karnowski, Alexander, Liddament, Mark T., Owczarek, Catherine M., Mahler, Stephen M., Panousis, Con, Jones, Martina L. and Fercher, Christian (2022). Evaluation of phage display biopanning strategies for the selection of anti-cell surface receptor antibodies. International Journal of Molecular Sciences, 23 (15) 8470, 8470. doi: 10.3390/ijms23158470
Journal Article: Engineering death resistance in CHO cells for improved perfusion culture
MacDonald, Michael A., Nöbel, Matthias, Martínez, Verónica S., Baker, Kym, Shave, Evan, Gray, Peter P., Mahler, Stephen, Munro, Trent, Nielsen, Lars K. and Marcellin, Esteban (2022). Engineering death resistance in CHO cells for improved perfusion culture. mAbs, 14 (1) e2083465, 1-13. doi: 10.1080/19420862.2022.2083465
ACRF Facility for Targeted Radiometals in Cancer (AFTRiC)
(2021–2023) Australian Cancer Research Foundation
An integrated, multi-node bio-layer interferometry facility
(2020–2021) ARC Linkage Infrastructure, Equipment and Facilities
Smart affinity membranes for manufacture of high value therapeutic proteins
(2019–2022) ARC Linkage Projects
Characterising murine red blood cell phenotypes: the impact of genetic variants in Klf1 and Casd1
(2021) Doctor Philosophy
(2020) Doctor Philosophy
(2019) Doctor Philosophy
Disease-modifying anti-rheumatic drugs
Pile, Kevin D., Graham, Garry G., Mahler, Stephen M. and Day, Richard O. (2019). Disease-modifying anti-rheumatic drugs. Nijkamp and Parnham’s principles of immunopharmacology. (pp. 709-750) edited by Michael J. Parnham, Frans P. Nijkamp and Adriano G. Rossi. Cham, Switzerland: Springer. doi: 10.1007/978-3-030-10811-3_34
Selection of antibodies to transiently expressed membrane proteins using phage display
Jones, Martina L., Mahler, Stephen M. and Kumble, Sumukh (2018). Selection of antibodies to transiently expressed membrane proteins using phage display. Antibody engineering. (pp. 179-195) edited by Damien Nevoltris and Patrick Chames. New York, NY, United States: Springer. doi: 10.1007/978-1-4939-8648-4_10
Interleukin-12/23 Inhibitors: Ustekinumab
Pile, Kevin D., Graham, Garry G. and Mahler, Stephen M. (2016). Interleukin-12/23 Inhibitors: Ustekinumab. Encyclopedia of Inflammatory Diseases. (pp. 1-3) edited by Michael J. Parnham. Basel Switzerland: Springer. doi: 10.1007/978-3-0348-0620-6_232-1
Pile, Kevin D., Graham, Garry G. and Mahler, Stephen M. (2015). CD20 Inhibitors: Rituximab. Encyclopedia of Inflammatory Diseases. (pp. 1-4) edited by Michael J. Parnham. Basel Switzerland: Springer. doi: 10.1007/978-3-0348-0620-6_21-1
Pile, Kevin D., Graham, Garry G. and Mahler, Stephen M. (2015). CD80/CD86 Inhibitors. Encyclopedia of Inflammatory Diseases. (pp. 1-4) edited by Michael J. Parnham. Basel Switzerland: Springer. doi: 10.1007/978-3-0348-0620-6_20-1
Disease-Modifying Anti-Rheumatic Drugs
Pile, Kevin D., Graham, Garry G. and Mahler, Stephen M. (2015). Disease-Modifying Anti-Rheumatic Drugs. Encyclopedia of Inflammatory Diseases. (pp. 1-13) edited by Michael J. Parnham. Basel Switzerland: Springer. doi: 10.1007/978-3-0348-0620-6_48-1
Pile, Kevin D., Graham, Garry G. and Mahler, Stephen M. (2015). Interleukin 1 Inhibitors. Encyclopedia of Inflammatory Diseases. (pp. 1-5) edited by Michael J. Parnham. Basel Switzerland: Springer. doi: 10.1007/978-3-0348-0620-6_29-1
Interleukin-6 Inhibitor – Tocilizumab
Pile, Kevin D., Graham, Garry G. and Mahler, Stephen M. (2015). Interleukin-6 Inhibitor – Tocilizumab. Encyclopedia of Inflammatory Diseases. (pp. 1-5) edited by Michael J. Parnham. Basel Switzerland: Springer. doi: 10.1007/978-3-0348-0620-6_231-1
Pile, Kevin D., Graham, Garry G. and Mahler, Stephen M. (2015). TNF Inhibitors. Encyclopedia of Inflammatory Diseases. (pp. 1-10) edited by Michael J. Parnham. Basel Switzerland: Springer. doi: 10.1007/978-3-0348-0620-6_67-1
Nouwens, Amanda and Mahler, Stephen (2012). Evolution of proteomic methods for analysis of complex biological samples - implications for personalized medicine.. Integrative Proteomics. (pp. 29-43) edited by Hon-Chiu Eastwood Leung, Tsz-Kwong Man and Ricardo J. Flores. Croatia: InTech. doi: 10.5772/29613
C15 disease-modifying antirheumatic drugs
Pile, Kevin D., Graham, Garry G., Mahler, Stephen M. and Day, Richard O. (2011). C15 disease-modifying antirheumatic drugs. Principles of immunopharmacology. (pp. 585-619) edited by Frans P. Nijkamp and Michael J. Parnham. Basel, Switzerland: Springer. doi: 10.1007/978-3-0346-0136-8_30
Downstream processing of monoclonal antibodies produced by cell culture techniques
Mahler, S. M. (1995). Downstream processing of monoclonal antibodies produced by cell culture techniques. Fundamental and applied aspects of animal cell culture. (pp. 197-232) edited by J. P. Barford, C. Harbour, C. P. Marquis, R. Malik, S. Mahler and P. J. Phillips. Singapore: Singapore University Press.
Protein engineering and diagnostic techniques
Mahler, Stephen M. (1990). Protein engineering and diagnostic techniques. Directions in Modern Biotechnology. (pp. 51-71) edited by Pauline M. Doran. Melbourne, VIC, Australia: Hawker Brownlow Education.
Design of polarity-dependent immunosensors based on the structural analysis of engineered antibodies
Islam, Jiaul, Conroy, Paul, Fercher, Christian, Kim, Mijin, Yaari, Zvi, Jones, Martina, Bell, Toby D. M., Caradoc-Davies, Tom, Law, Ruby, Whisstock, James, Heller, Daniel, Mahler, Stephen and Corrie, Simon (2023). Design of polarity-dependent immunosensors based on the structural analysis of engineered antibodies. ACS Chemical Biology, 18 (8), 1863-1871. doi: 10.1021/acschembio.3c00303
Panagides, Nadya, Zacchi, Lucia F., Souza, Mitchell J. De, Morales, Rodrigo A. V., Karnowski, Alexander, Liddament, Mark T., Owczarek, Catherine M., Mahler, Stephen M., Panousis, Con, Jones, Martina L. and Fercher, Christian (2022). Evaluation of phage display biopanning strategies for the selection of anti-cell surface receptor antibodies. International Journal of Molecular Sciences, 23 (15) 8470, 8470. doi: 10.3390/ijms23158470
Engineering death resistance in CHO cells for improved perfusion culture
MacDonald, Michael A., Nöbel, Matthias, Martínez, Verónica S., Baker, Kym, Shave, Evan, Gray, Peter P., Mahler, Stephen, Munro, Trent, Nielsen, Lars K. and Marcellin, Esteban (2022). Engineering death resistance in CHO cells for improved perfusion culture. mAbs, 14 (1) e2083465, 1-13. doi: 10.1080/19420862.2022.2083465
Janowicz, Phillip W., Houston, Zachary H., Bunt, Jens, Fletcher, Nicholas L., Bell, Craig A., Cowin, Gary, Howard, Christopher B., Taslima, Dewan, Westra van Holthe, Nicholas, Prior, Amber, Soh, Vanessa, Ghosh, Saikat, Humphries, James, Huda, Pie, Mahler, Stephen M., Richards, Linda J. and Thurecht, Kristofer J. (2022). Understanding nanomedicine treatment in an aggressive spontaneous brain cancer model at the stage of early blood brain barrier disruption. Biomaterials, 283 121416, 121416. doi: 10.1016/j.biomaterials.2022.121416
Modelling apoptosis resistance in CHO cells with CRISPR‐mediated knock‐outs of Bak1, Bax, and Bok
MacDonald, Michael A., Barry, Craig, Groves, Teddy, Martínez, Verónica S., Gray, Peter P., Baker, Kym, Shave, Evan, Mahler, Stephen, Munro, Trent, Marcellin, Esteban and Nielsen, Lars K. (2022). Modelling apoptosis resistance in CHO cells with CRISPR‐mediated knock‐outs of Bak1, Bax, and Bok. Biotechnology and Bioengineering, 119 (6), 1380-1391. doi: 10.1002/bit.28062
Navone, Laura, Vogl, Thomas, Luangthongkam, Pawarisa, Blinco, Jo-Anne, Luna-Flores, Carlos H., Chen, Xiaojing, von Hellens, Juhani, Mahler, Stephen and Speight, Robert (2021). Disulfide bond engineering of AppA phytase for increased thermostability requires co-expression of protein disulfide isomerase in Pichia pastoris. Biotechnology for Biofuels, 14 (1) 80, 80. doi: 10.1186/s13068-021-01936-8
In silico molecular dynamics of human glycophorin A (GPA) extracellular structure
Ekman, Serena, Flower, Robert, Mahler, Stephen, Gould, Alison, Barnard, Ross T., Hyland, Catherine, Jones, Martina, Malde, Alpeshkumar K. and Bui, Xuan T. (2021). In silico molecular dynamics of human glycophorin A (GPA) extracellular structure. Annals of Blood, 6 (June) 11. doi: 10.21037/aob-20-51
Zacchi, Lucia F., Roche-Recinos, Dinora, Pegg, Cassandra L., Phung, Toan K., Napoli, Mark, Aitken, Campbell, Sandford, Vanessa, Mahler, Stephen M., Lee, Yih Yean, Schulz, Benjamin L. and Howard, Christopher B. (2021). Coagulation factor IX analysis in bioreactor cell culture supernatant predicts quality of the purified product. Communications Biology, 4 (1) 390, 390. doi: 10.1038/s42003-021-01903-x
Recombinant antibody engineering enables reversible binding for continuous protein biosensing
Fercher, Christian, Jones, Martina L., Mahler, Stephen M. and Corrie, Simon R (2021). Recombinant antibody engineering enables reversible binding for continuous protein biosensing. ACS Sensors, 6 (3) acssensors.0c01510, 764-776. doi: 10.1021/acssensors.0c01510
Wardiana, Andri, Jones, Martina L., Mahler, Stephen M. and Howard, Christopher B. (2021). Incorporation of unnatural amino acid into antibody fragment for creating a stable antibody-drug conjugate. Indonesian Journal of Pharmacy, 32 (1), 96-105. doi: 10.22146/ijp.1101
Perfusion culture of Chinese Hamster Ovary cells for bioprocessing applications
MacDonald, Michael A., Nöbel, Matthias, Roche Recinos, Dinora, Martínez, Verónica S., Schulz, Benjamin L., Howard, Christopher B., Baker, Kym, Shave, Evan, Lee, Yih Yean, Marcellin, Esteban, Mahler, Stephen, Nielsen, Lars Keld and Munro, Trent (2021). Perfusion culture of Chinese Hamster Ovary cells for bioprocessing applications. Critical Reviews in Biotechnology, 42 (7), 1-17. doi: 10.1080/07388551.2021.1998821
Lund, Maria E., Howard, Christopher B., Thurecht, Kristofer J., Campbell, Douglas H., Mahler, Stephen M. and Walsh, Bradley J. (2020). A bispecific T cell engager targeting Glypican-1 redirects T cell cytolytic activity to kill prostate cancer cells. BMC Cancer, 20 (1) 1214, 1214. doi: 10.1186/s12885-020-07562-1
McGowan, Eunike C., Flower, Robert L., Jones, Martina L., Irving, David O., Barnard, Ross T., Hyland, Catherine A., Mahler, Stephen M. and Bui, Xuan T. (2020). Aggregates in blood filter chambers used from the plasma donations of anti-D donors: evaluation for monoclonal antibody discovery using phage display. Blood Transfusion , 19 (1), 64-72. doi: 10.2450/2020.0093-20
Controlling the biological fate of micellar nanoparticles: balancing stealth and targeting
Sivaram, Amal J., Wardiana, Andri, Alcantara, Sheilajen, Sonderegger, Stefan E., Fletcher, Nicholas L., Houston, Zachary H., Howard, Christopher B., Mahler, Stephen M., Alexander, Cameron, Kent, Stephen J., Bell, Craig A. and Thurecht, Kristofer J. (2020). Controlling the biological fate of micellar nanoparticles: balancing stealth and targeting. ACS Nano, 14 (10) acsnano.0c06033, 13739-13753. doi: 10.1021/acsnano.0c06033
‘Omics driven discoveries of gene targets for apoptosis attenuation in CHO cells
Orellana, Camila A., Martínez, Verónica S., MacDonald, Michael A., Henry, Matthew N., Gillard, Marianne, Gray, Peter P., Nielsen, Lars K., Mahler, Stephen and Marcellin, Esteban (2020). ‘Omics driven discoveries of gene targets for apoptosis attenuation in CHO cells. Biotechnology and Bioengineering, 118 (1) bit.27548, 481-490. doi: 10.1002/bit.27548
Phage display derived monoclonal antibodies: from bench to bedside
Alfaleh, Mohamed A., Alsaab, Hashem O., Mahmoud, Ahmad Bakur, Alkayyal, Almohanad A., Jones, Martina L., Mahler, Stephen M. and Hashem, Anwar M. (2020). Phage display derived monoclonal antibodies: from bench to bedside. Frontiers in Immunology, 11 1986, 1986. doi: 10.3389/fimmu.2020.01986
Targeting the undruggable: emerging technologies in antibody delivery against intracellular targets
Niamsuphap, Suchada, Fercher, Christian, Kumble, Sumukh, Huda, Pie, Mahler, Stephen M. and Howard, Christopher B. (2020). Targeting the undruggable: emerging technologies in antibody delivery against intracellular targets. Expert Opinion on Drug Delivery, 17 (9), 1189-1211. doi: 10.1080/17425247.2020.1781088
Houston, Zachary H., Bunt, Jens, Chen, Kok-Siong, Puttick, Simon, Howard, Christopher B., Fletcher, Nicholas L., Fuchs, Adrian V., Cui, Jiwei, Ju, Yi, Cowin, Gary, Song, Xin, Boyd, Andrew W., Mahler, Stephen M., Richards, Linda J., Caruso, Frank and Thurecht, Kristofer J. (2020). Understanding the uptake of nanomedicines at different stages of brain cancer using a modular nanocarrier platform and precision bispecific antibodies. ACS Central Science, 6 (5) acscentsci.9b01299, 727-738. doi: 10.1021/acscentsci.9b01299
Playford, Elliott Geoffrey, Munro, Trent, Mahler, Stephen M., Elliott, Suzanne, Gerometta, Michael, Hoger, Kym L., Jones, Martina L., Griffin, Paul, Lynch, Kathleen D., Carroll, Heidi, El Saadi, Debra, Gilmour, Margaret E., Hughes, Benjamin, Hughes, Karen, Huang, Edwin, de Bakker, Christopher, Klein, Reuben, Scher, Mark G., Smith, Ina L., Wang, Lin-Fa, Lambert, Stephen B., Dimitrov, Dimiter S., Gray, Peter P. and Broder, Christopher C. (2020). Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study. The Lancet Infectious Diseases, 20 (4), 445-454. doi: 10.1016/S1473-3099(19)30634-6
Attenuating apoptosis in Chinese hamster ovary cells for improved biopharmaceutical production
Henry, Matthew N., MacDonald, Michael A., Orellana, Camila A., Gray, Peter P., Gillard, Marianne, Baker, Kym, Nielsen, Lars K., Marcellin, Esteban, Mahler, Stephen and Martinez, Veronica S. (2020). Attenuating apoptosis in Chinese hamster ovary cells for improved biopharmaceutical production. Biotechnology and Bioengineering, 117 (4) bit.27269, 1187-1203. doi: 10.1002/bit.27269
Ediriweera, Gayathri R., Simpson, Joshua D., Fuchs, Adrian V., Venkatachalam, Taracad K., Van De Walle, Matthias, Howard, Christopher B., Mahler, Stephen M., Blinco, James P., Fletcher, Nicholas L., Houston, Zachary H., Bell, Craig A. and Thurecht, Kristofer J. (2020). Targeted and modular architectural polymers employing bioorthogonal chemistry for quantitative therapeutic delivery. Chemical Science, 11 (12), 3268-3280. doi: 10.1039/d0sc00078g
Retooling phage display with electrohydrodynamic nanomixing and nanopore sequencing
Raftery, Lyndon J., Howard, Christopher B., Grewal, Yadveer S., Vaidyanathan, Ramanathan, Jones, Martina L., Anderson, Will, Korbie, Darren, Duarte, Tania, Duc Cao, Minh, Nguyen, Son Hoang, Coin, Lachlan JM, Mahler, Stephen M and Trau, Matt (2019). Retooling phage display with electrohydrodynamic nanomixing and nanopore sequencing. Lab on a Chip, 19 (24), 4083-4092. doi: 10.1039/c9lc00978g
Tang, Jie, Li, Bei, Howard, Christopher B., Mahler, Stephen M., Thurecht, Kristofer J., Wu, Yilun, Huang, Leaf and Xu, Zhi Ping (2019). Multifunctional lipid-coated calcium phosphate nanoplatforms for complete inhibition of large triple negative breast cancer via targeted combined therapy. Biomaterials, 216 119232, 119232. doi: 10.1016/j.biomaterials.2019.119232
Islam, Jiaul, Riley, Blake T., Fercher, Christian, Jones, Martina L., Buckle, Ashley M., Howard, Christopher B., Cox, Rosalind P., Bell, Toby D. M., Mahler, Stephen and Corrie, Simon R. (2019). Wavelength-dependent fluorescent immunosensors via incorporation of polarity indicators near the binding interface of antibody fragments. Analytical Chemistry, 91 (12), 7631-7638. doi: 10.1021/acs.analchem.9b00445
Innovative therapeutic strategies for effective treatment of brain metastases
Lim, Malcolm, Puttick, Simon, Houston, Zachary H., Thurecht, Kristofer J., Kalita-de Croft, Priyakshi, Mahler, Stephen, Rose, Stephen E., Jeffree, Rosalind L., Mazzieri, Roberta, Dolcetti, Riccardo, Lakhani, Sunil R. and Saunus, Jodi M. (2019). Innovative therapeutic strategies for effective treatment of brain metastases. International Journal of Molecular Sciences, 20 (6) 1280. doi: 10.3390/ijms20061280
Modulating targeting of poly(ethylene glycol) particles to tumor cells using bispecific antibodies
Cui, Jiwei, Ju, Yi, Houston, Zachary H., Glass, Joshua J., Fletcher, Nicholas L., Alcantara, Sheilajen, Dai, Qiong, Howard, Christopher B., Mahler, Stephen M., Wheatley, Adam K., De Rose, Robert, Brannon, Paul T., Paterson, Brett M., Donnelly, Paul S., Thurecht, Kristofer J., Caruso, Frank and Kent, Stephen J. (2019). Modulating targeting of poly(ethylene glycol) particles to tumor cells using bispecific antibodies. Advanced Healthcare Materials, 8 (9) 1801607, e1801607. doi: 10.1002/adhm.201801607
Alfaleh, Mohamed, Arora, Neetika, Yeh, Michael, de Bakker, Christopher, Howard, Christopher, Macpherson, Philip, Allavena, Rachel, Chen, Xiaoli, Harkness, Linda, Mahler, Stephen and Jones, Martina (2019). Canine CD117-Specific Antibodies with Diverse Binding Properties Isolated from a Phage Display Library Using Cell-Based Biopanning. Antibodies, 8 (1) 15, 15. doi: 10.3390/antib8010015
Li, Junrong, Wang, Jing, Grewal, Yadveer S, Howard, Christopher B, Raftery, Lyndon J, Mahler, Stephen, Wang, Yuling and Trau, Matt (2018). Multiplexed SERS detection of soluble cancer protein biomarkers with gold-silver alloy nanoboxes and nanoyeast single-chain variable fragments. Analytical Chemistry, 90 (17) acs.analchem.8b02216, 10377-10384. doi: 10.1021/acs.analchem.8b02216
Fontaine, Frank R., Goodall, Stephen, Prokop, Jeremy W., Howard, Christopher B., Moustaqil, Mehdi, Kumble, Sumukh, Rasicci, Daniel T., Osborne, Geoffrey W., Gambin, Yann, Sierecki, Emma, Jones, Martina L., Zuegg, Johannes, Mahler, Stephen and Francois, Mathias (2018). Functional domain analysis of SOX18 transcription factor using a single-chain variable fragment-based approach. mAbs, 10 (4), 1-11. doi: 10.1080/19420862.2018.1451288
Tang, Jie, Howard, Christopher B., Mahler, Stephen M., Thurecht, Kristofer J., Huang, Leaf and Xu, Zhi Ping (2018). Enhanced delivery of siRNA to triple negative breast cancer cells in vitro and in vivo through functionalizing lipid-coated calcium phosphate nanoparticles with dual target ligands. Nanoscale, 10 (9), 4258-4266. doi: 10.1039/c7nr08644j
Recent advances in the generation of antibody-nanomaterial conjugates
Sivaram, Amal J, Wardiana, Andri, Howard, Christopher B, Mahler, Stephen M and Thurecht, Kristofer J (2018). Recent advances in the generation of antibody-nanomaterial conjugates. Advanced Healthcare Materials, 7 (1) 1700607. doi: 10.1002/adhm.201700607
Alfaleh, Mohamed A., Howard, Christopher B., Sedliarou, Ilya, Jones, Martina L., Gudhka, Reema, Vanegas, Natasha, Weiss, Jocelyn, Suurbach, Julia H., de Bakker, Christopher J., Milne, Michael R., Rumballe, Bree A., MacDiarmid, Jennifer A., Brahmbhatt, Himanshu and Mahler, Stephen M. (2017). Targeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tumour growth in mouse xenograft models. Plos One, 12 (10) e0186137, e0186137. doi: 10.1371/journal.pone.0186137
Tayeb, Hossam H, Piantavigna, Stefania, Howard, Christopher B, Nouwens, Amanda, Mahler, Stephen M, Middelberg, Anton P J, He, Lizhong, Holt, Stephen A and Sainsbury, Frank (2017). Insights into the interfacial structure-function of poly(ethylene glycol)-decorated peptide-stabilised nanoscale emulsions. Soft matter, 13 (43), 7953-7961. doi: 10.1039/c7sm01614j
Cell-free pipeline for discovery of thermotolerant xylanases and endo-1,4-β-glucanases
Gagoski, Dejan, Shi, Zhenyu, Nielsen, Lars Keld, Vickers, Claudia E., Mahler, Stephen, Speight, Robert, Johnston, Wayne A. and Alexandrov, Kirill (2017). Cell-free pipeline for discovery of thermotolerant xylanases and endo-1,4-β-glucanases. Journal of Biotechnology, 259, 191-198. doi: 10.1016/j.jbiotec.2017.07.014
Alfaleh, Mohamed A., Jones, Martina L., Howard, Christopher B. and Mahler, Stephen M. (2017). Strategies for Selecting Membrane Protein-Specific Antibodies using Phage Display with Cell-Based Panning. Antibodies, 6 (3) 10, 1-19. doi: 10.3390/antib6030010
Mahler, Stephen (2017). Safety of biologics therapy: monoclonal antibodies, cytokines, fusion proteins, hormones, enzymes, coagulation proteins, vaccines, botulinum toxins. mAbs, 9 (6), 885-888. doi: 10.1080/19420862.2017.1343709
Lebani, Kebaneilwe, Jones, Martina L., Watterson, Daniel, Ranzoni, Andrea, Traves, Renee J., Young, Paul R. and Mahler, Stephen M. (2017). Isolation of serotype-specific antibodies against dengue virus non-structural protein 1 using phage display and application in a multiplexed serotyping assay. PLoS One, 12 (7) e0180669, e0180669. doi: 10.1371/journal.pone.0180669
Computational identification of antibody epitopes on the dengue virus NS1 protein
Jones, Martina L., Legge, Fiona S., Lebani, Kebaneilwe, Mahler, Stephen M., Young, Paul R., Watterson, Daniel, Treutlein, Herbert R. and Zeng, Jun (2017). Computational identification of antibody epitopes on the dengue virus NS1 protein. Molecules, 22 (4) 607, 607. doi: 10.3390/molecules22040607
Beyond antibodies: development of a novel protein scaffold based on human chaperonin 10
Alsultan, Abdulkarim M., Chin, David Y., Howard, Christopher B., de Bakker, Christopher J., Jones, Martina L. and Mahler, Stephen M. (2016). Beyond antibodies: development of a novel protein scaffold based on human chaperonin 10. Scientific Reports, 5 (37348) 37348, 37348. doi: 10.1038/srep37348
Nanoyeast and other cell envelope compositions for protein studies and biosensor applications
Grewal, Yadveer S., Shiddiky, Muhammad J. A., Mahler, Stephen M., Cangelosi, Gerard A. and Trau, Matt (2016). Nanoyeast and other cell envelope compositions for protein studies and biosensor applications. ACS Applied Materials and Interfaces, 8 (45), 30649-30664. doi: 10.1021/acsami.6b09263
Biosimilars approved for treatment of inflammatory rheumatological diseases
Mahler, Stephen M., Wardiana, Andri, Jones, Martina L., De Bakker, Christopher J., Graham, Garry G. and Howard, Christopher B. (2016). Biosimilars approved for treatment of inflammatory rheumatological diseases. International Journal of Rheumatic Diseases, 19 (11), 1043-1048. doi: 10.1111/1756-185X.13037
Howard, Christopher B., Fletcher, Nicholas, Houston, Zachary H., Fuchs, Adrian V., Boase, Nathan R. B., Simpson, Joshua D., Raftery, Lyndon J., Ruder, Tim, Jones, Martina L., de Bakker, Christopher J., Mahler, Stephen M. and Thurecht, Kristofer J. (2016). Targeted nanomaterials: overcoming instability of antibody-nanomaterial conjugates: next generation targeted nanomedicines using bispecific antibodies (Adv. Healthcare Mater. 16/2016). Advanced Healthcare Materials, 5 (16), 1994-1994. doi: 10.1002/adhm.201670084
Howard, Christopher B., Fletcher, Nicholas, Houston, Zachary H., Fuchs, Adrian V., Boase, Nathan R. B., Simpson, Joshua D., Raftery, Lyndon J., Ruder, Tim, Jones, Martina L., de Bakker, Christopher J., Mahler, Stephen M. and Thurecht, Kristofer J. (2016). Overcoming Instability of Antibody-Nanomaterial Conjugates: Next Generation Targeted Nanomedicines Using Bispecific Antibodies. Advanced Healthcare Materials, 5 (16), 2055-2068. doi: 10.1002/adhm.201600263
Targeting membrane proteins for antibody discovery using phage display
Jones, Martina L., Alfaleh, Mohamed A., Kumble, Sumukh, Zhang, Shuo, Osborne, Geoffrey W., Yeh, Michael, Arora, Neetika, Hou, Jeff Jia Cheng, Howard, Christopher B., Chin, David Y. and Mahler, Stephen M. (2016). Targeting membrane proteins for antibody discovery using phage display. Scientific Reports, 6 (1) 26240, 26240. doi: 10.1038/srep26240
Fromm, Phillip D., Papadimitrious, Michael S., Hsu, Jennifer L., Van Kooten Losio, Nicolas, Verma, Nirupama D., Lo, Tsun Ho, Silveira, Pablo A., Bryant, Christian E., Turtle, Cameron J., Prue, Rebecca L., Vukovic, Peter, Munster, David J., Nagasaki, Tomoko, Barnard, Ross T., Mahler, Stephen M., Anguille, Sébastien A., Berneman, Zwi, Horvath, Lisa G., Bradstock, Kenneth F., Joshua, Douglas E., Clark, Georgina J. and Hart, Derek N. J. (2016). CMRF-56+ blood dendritic cells loaded with mRNA induce effective antigen-specific cytotoxic T lymphocyte responses. OncoImmunology, 5 (6) e1168555, e1168555. doi: 10.1080/2162402X.2016.1168555
Biosensing made easy with PEG-targeted bi-specific antibodies
Raftery, Lyndon J., Grewal, Yadveer S., Howard, Christopher B., Jones, Martina L., Shiddiky, Muhammad J. A., Carrascosa, Laura G., Thurecht, Kristofer J., Mahler, Stephen M. and Trau, Matt (2016). Biosensing made easy with PEG-targeted bi-specific antibodies. Chemical Communications, 52 (33), 5730-5733. doi: 10.1039/C6CC01916A
Seldon, T. A., Pryor, R., Palkova, A., Jones, M. L., Verma, N. D., Findova, M., Braet, K., Sheng, Y., Fan, Y., Zhou, Y. Y., Marks, J. D., Munro, T., Mahler, S. M., Barnard, R. T., Fromm, P. D., Silveira, P. A., Elgundi, Z., Ju, X., Clark, G. J., Bradstock, K. F., Munster, D. J. and Hart, D. N. J. (2015). Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation.. Leukemia, 30 (3), 692-700. doi: 10.1038/leu.2015.231
Diao, Mengxue, Nguyen, Tuan A.H., Taran, Elena, Mahler, Stephen M. and Nguyen, Anh V. (2015). Effect of energy source, salt concentration and loading force on colloidal interactions between Acidithiobacillus ferrooxidans cells and mineral surfaces. Colloids and Surfaces B: Biointerfaces, 132, 271-280. doi: 10.1016/j.colsurfb.2015.05.026
Tang, Jie, Li, Li, Howard, Christopher B., Mahler, Stephen M., Huang, Leaf and Xu, Zhi Ping (2015). Preparation of optimized lipid-coated calcium phosphate nanoparticles for enhanced in vitro gene delivery to breast cancer cells. Journal of Materials Chemistry B, 3 (33), 6805-6812. doi: 10.1039/c5tb00912j
Mahler, Stephen and Roy, Ipsita (2015). Advances in drug delivery. Journal of Chemical Technology and Biotechnology, 90 (7), 1167-1168. doi: 10.1002/jctb.4689
Naylor, Dean J., Hunt, Ben, Guidolin, Angelo, Hey, Allan W., Bastiras, Stan, de Bakker, Christopher J., Chin, David Y., Marquis, Christopher P., Lambert, Daniel, Howard, Christopher B., Dobbin, Caroline A. and Mahler, Stephen M. (2015). Production and characterisation of recombinant human chaperonin 10 for treatment of inflammatory disease. Process Biochemistry, 50 (10) 10466, 1669-1679. doi: 10.1016/j.procbio.2015.06.022
Nanocell targeting using engineered bispecific antibodies.
Taylor, Karin, Howard, Christopher B., Jones, Martina L., Sedliarou, Ilya, MacDiarmid, Jennifer, Brahmbhatt, Himanshu, Munro, Trent P. and Mahler, Stephen M. (2014). Nanocell targeting using engineered bispecific antibodies.. mAbs, 7 (1), 53-65. doi: 10.4161/19420862.2014.985952
Monoclonal antibody-targeted polymeric nanoparticles for cancer therapy - future prospects
Goodall, Stephen, Jones, Martina L. and Mahler, Stephen (2014). Monoclonal antibody-targeted polymeric nanoparticles for cancer therapy - future prospects. Journal of Chemical Technology and Biotechnology, 90 (7), 1169-1176. doi: 10.1002/jctb.4555
Development of a protein nanoparticle platform for targeting EGFR expressing cancer cells
Buecheler, Jakob W., Howard, Christopher B., de Bakker, Christopher J., Goodall, Stephen, Jones, Martina L, Win, Thinzar, Peng, Tao, Tan, Cher Heng, Chopra, Akhil, Mahler, Stephen M and Lim, Sierin (2014). Development of a protein nanoparticle platform for targeting EGFR expressing cancer cells. Journal of Chemical Technology and Biotechnology, 90 (7), 1230-1236. doi: 10.1002/jctb.4545
A concise review of nanoscopic aspects of bioleaching bacteria-mineral interactions
Diao, Mengxue, Taran, Elena, Mahler, Stephen and Nguyen, Anh V. (2014). A concise review of nanoscopic aspects of bioleaching bacteria-mineral interactions. Advances in Colloid and Interface Science, 212, 45-63. doi: 10.1016/j.cis.2014.08.005
An EGFR targeting nanoparticle self assembled from a thermoresponsive polymer
Goodall, Stephen, Howard, Christopher B., Jones, Martina L., Munro,Trent, Jia, Zhongfan, Monteiro, Michael J and Mahler, Stephen (2014). An EGFR targeting nanoparticle self assembled from a thermoresponsive polymer. Journal of Chemical Technology and Biotechnology, 90 (7), 1222-1229. doi: 10.1002/jctb.4509
Leow, Chiuan Herng, Jones, Martina, Cheng, Qin, Mahler, Strphen and McCarthy, James (2014). Production and characterization of specific monoclonal antibodies binding the Plasmodium falciparum diagnostic biomarker, histidine-rich protein 2. Malaria Journal, 13 (1) 277. doi: 10.1186/1475-2875-13-277
Diao, Mengxue, Nguyen, Tuan A. H., Taran, Elena, Mahler, Stephen and Nguyen, Anh V. (2014). Differences in adhesion of A. thiooxidans and A. ferrooxidans on chalcopyrite as revealed by atomic force microscopy with bacterial probes. Minerals Engineering, 61, 9-15. doi: 10.1016/j.mineng.2014.03.002
Diao, Mengxue, Taran, Elena, Mahler, Stephen, Nguyen, Tuan A. H. and Nguyen, Anh V. (2014). Quantifying adhesion of acidophilic bioleaching bacteria to silica and pyrite by atomic force microscopy with a bacterial probe. Colloids and Surfaces B: Biointerfaces, 115, 229-236. doi: 10.1016/j.colsurfb.2013.11.047
Diao, Mengxue, Taran, Elena, Mahler, Stephen M. and Nguyen, Anh V. (2014). Comparison and evaluation of immobilization methods for preparing bacterial probes using acidophilic bioleaching bacteria Acidithiobacillus thiooxidans for AFM studies. Journal of Microbiological Methods, 102, 12-14. doi: 10.1016/j.mimet.2014.04.004
Munro, Trent P., Mahler, Stephen M., Huang, Edwin P., Chin, David Y. and Gray, Peter P. (2011). Bridging the gap: Facilities and technologies for development of early stage therapeutic mAb candidates. mAbs, 3 (5), 440-452. doi: 10.4161/mabs.3.5.16968
Analytical strategies for assessing comparability of biosimilars
Falconer, Robert J., Jackson-Matthews, Dianne and Mahler, Stephen M. (2011). Analytical strategies for assessing comparability of biosimilars. Journal of Chemical Technology and Biotechnology, 86 (7), 915-922. doi: 10.1002/jctb.2629
Song, Michael, Raphaelli, Kristin, Jones, Martina L., Aliabadi-Zadeh, Khosrow, Leung, Kar Man, Crowley, David, Hughes, Benjamin, Mahler, Stephen, Gray, Peter P., Huang, Edwin P. and Chin, David Y. (2011). Clonal selection of high producing, stably transfected HEK293 cell lines utilizing modified, high-throughput FACS screening. Journal of Chemical Technology and Biotechnology, 86 (7), 935-941. doi: 10.1002/jctb.2618
Biologics and biosimilars: emerging technologies driving global opportunity
Mahler, Stephen and Gray, Peter (2011). Biologics and biosimilars: emerging technologies driving global opportunity. Journal of Chemical Technology & Biotechnology, 86 (7), 893-894. doi: 10.1002/jctb.2684
Disease-specific, neurosphere-derived cells as models for brain disorders
Matigian, N, Abrahamsen, G, Sutharsan, R, Cook, AL, Vitale, AM, Nouwens, A, Bellette, B, An, JY, Anderson, M, Beckhouse, AG, Bennebroek, M, Cecil, R, Chalk, AM, Cochrane, J, Fan, YJ, Feron, F, McCurdy, R, McGrath, JJ, Murrell, W, Perry, C, Raju, J, Ravishankar, S, Silburn, PA, Sutherland, GT, Mahler, S, Mellick, GD, Wood, SA, Sue, CM, Wells, CA and Mackay-Sim, A (2010). Disease-specific, neurosphere-derived cells as models for brain disorders. Disease Models and Mechanisms, 3 (11-12), 785-798. doi: 10.1242/dmm.005447
A method for rapid, ligation-independent reformatting of recombinant monoclonal antibodies
Jones, Martina L., Seldon, Therese, Smede, Matthew, Linville, Ashleigh, Chin, David Y., Barnard, Ross, Mahler, Stephen M., Munster, David, Hart, Derek, Gray, Peter P. and Munro, Trent P. (2010). A method for rapid, ligation-independent reformatting of recombinant monoclonal antibodies. Journal of Immunological Methods, 354 (1-2), 85-90. doi: 10.1016/j.jim.2010.02.001
de Leon, EJ, Yuan, FF, Pearson, H, Marquis, CP and Mahler, SM (2009). Evidence of heterogeneity in the antibody response against the platelet antigen 3a; recognition of an 11-mer peptide carrying the HPA-3a polymorphic determinant. VOX SANGUINIS, 96 (3), 252-255. doi: 10.1111/j.1423-0410.2008.01146.x
A sensitive and specific ELISA detects methionine sulfoxide-containing apolipoprotein A-I in HDL
Wang, XS, Shao, BH, Oda, MN, Heinecke, JW, Mahler, S and Stocker, R (2009). A sensitive and specific ELISA detects methionine sulfoxide-containing apolipoprotein A-I in HDL. JOURNAL OF LIPID RESEARCH, 50 (3), 586-594. doi: 10.1194/jlr.D800042-JLR200
BioPEGylation of Polyhydroxyalkanoates: Influence on Properties and Satellite-Stem Cell Cycle
Marcal, Helder, Wanandy, Nico S., Sanguanchaipaiwong, Vorapat, Woolnough, Catherine E., Lauto, Antonio, Mahler, Stephen M. and Foster, L. John R. (2008). BioPEGylation of Polyhydroxyalkanoates: Influence on Properties and Satellite-Stem Cell Cycle. Biomacromolecules, 9 (10), 2719-2726. doi: 10.1021/bm800418e
Expression proteomics of olfactory ensheathing cells
Marcal, Helder, Sarris, Maria, Raftery, Mark J., Bhasin, Vishal, McFarland, Clive and Mahler, Stephen M. (2008). Expression proteomics of olfactory ensheathing cells. Journal of Chemical Technology And Biotechnology, 83 (4), 473-481. doi: 10.1002/jctb.1900
In Focus: Stem cell and tissue engineering applications in regenerative medicine
Mahler, Stephen (2008). In Focus: Stem cell and tissue engineering applications in regenerative medicine. Journal of Chemical Technology and Biotechnology, 83 (4), 395-396. doi: 10.1002/jctb.1933
The macrophage-biomaterial interface: a proteomic analysis of the conditioned medium environment
Dinnes, Donna Lee M., Marcal, Helder, Raftery, Mark J., Labow, Rosalind S. and Mahler, Stephen M. (2008). The macrophage-biomaterial interface: a proteomic analysis of the conditioned medium environment. Journal of Chemical Technology And Biotechnology, 83 (4), 482-495. doi: 10.1002/jctb.1854
Cytotoxic activity of CD48 monoclonal antibodies against human lymphoma cells
Wei, Jiewei, Chin, David Y. and Mahler, Stephen M. (2008). Cytotoxic activity of CD48 monoclonal antibodies against human lymphoma cells. Open Biotechnology Journal, 2 (1), 219-223. doi: 10.2174/1874070700802010219
Practical blood dendritic cell vaccination for immunotherapy of multiple myeloma
Vari F, Munster D.J., Hsu J.L., Rossetti T.R., Stephen Mahler, Gray, Peter P., Turtle C.J., Prue R.L. and Hart D.N. (2008). Practical blood dendritic cell vaccination for immunotherapy of multiple myeloma. British Journal Of Haematology, 143 (3), 374-377. doi: 10.1111/j.1365-2141.2008.07346.x
Material surfaces affect the protein expression patterns of human macrophages: A proteomics approach
Mahler, Stephen Michael, Dinnes, Donna Lee M., Marçal, Helder, Santerre, J. Paul and Labow, Rosalind S. (2007). Material surfaces affect the protein expression patterns of human macrophages: A proteomics approach. Journal of Biomedical Materials Research Part A, 80A (4), 895-908. doi: 10.1002/jbm.a.30967
Catzel, D., Chin, D. Y., Stanton, P. G., Gray, P. P. and Mahler, S. A. (2006). Fractionation of follicle stimulating hormone charge isoforms in their native form by preparative electrophoresis technology. Journal of Biotechnology, 122 (1), 73-85. doi: 10.1016/j.jbiotec.2005.08.026
Mahler, Stephen M., Leong, Sharon, Gilbert, Andrew, Yang, Fan, Gray, Peter, Van Dyk, Derek and Roeth, Philip (2006). Purification of monoclonal antibodies from cell culture supernatants by Gradiflow (TM) electrophoresis technology. Journal of Chemical Technology And Biotechnology, 81 (3), 445-453. doi: 10.1002/jctb.1426
Wei, J. W., Chin, D. Y., Catzel, D., Pera, N. and Mahler, S. M. (2005). Expression and characterisation of recombinant human CD48 and isolation of a human anti-CD48 monoclonal antibody by phage display. Journal of Chemical Technology And Biotechnology, 80 (7), 782-795. doi: 10.1002/jctb.1238
Purification of Fab fragments from a monoclonal antibody papain digest by Gradiflow electrophoresis
Coleman, L. and Mahler, S. M. (2003). Purification of Fab fragments from a monoclonal antibody papain digest by Gradiflow electrophoresis. Protein Expression And Purification, 32 (2), 246-251. doi: 10.1016/j.pep.2003.07.005
Foster, L. J. R., Catzel, D., Atwa, S., Zarka, M. and Mahler, S. M. (2003). Increase in synthesis of human monoclonal antibodies by transfected Sp2/0 myeloma mouse cell line under conditions of microgravity. Biotechnology Letters, 25 (15), 1271-1274. doi: 10.1023/A:1025003800414
The application of emerging technologies in genomics and proteomics to drug development
Mahler, S. M., Chin, D. Y. and Van Dyk, D. D. (2003). The application of emerging technologies in genomics and proteomics to drug development. Journal of Pharmacy Practice and Research, 33 (1), 7-11.
Catzel, D., Lalevski, H., Marquis, C. P., Gray, P. P., Van Dyk, D. and Mahler, S. M. (2003). Purification of recombinant human growth hormone from CHO cell culture supernatant by Gradiflow preparative electrophoresis technology. Protein Expression And Purification, 32 (1), 126-134. doi: 10.1016/j.pep.2003.07.002
Marquis, Christopher, Mahler, Stephen, Pearson, Helen and Barcho, Shane (2001, 04 01). Bleeding babies Australasian Science 37-39.
Philips, J. R., Brouwer, W., Mahler, S., Ruhno, J., Collins, A. M. and Edwards, M. (1999). The effectiveness of different rat IgG subclasses as IgE-blocking antibodies in the Rat Basophil Leukemia cell model. Immunology and Cell Biology, 77 (2), 121-126. doi: 10.1046/j.1440-1711.1999.00801.x
Wong, L, Pearson, H, Fletcher, A, Marquis, CP and Mahler, S (1998). Comparison of the efficiency of Moloney Murine Leukaemia Virus (M-MuLV) reverse transcriptase, RNase H--M-MuLV reverse transcriptase and Avian Myeloblastoma Leukaemia Virus (AMV) reverse transcriptase for the amplification of human immunoglobulin genes. Biotechnology Techniques, 12 (6), 485-489. doi: 10.1023/A:1008871608947
MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily
Bootcov, MR, Bauskin, AR, Valenzuela, SM, Moore, AG, Bansal, M, He, XY, Zhang, HP, Donnellan, M, Mahler, S, Pryor, K, Walsh, BJ, Nicholson, RC, Fairlie, WD, Por, SB, Robbins, JM and Breit, SN (1997). MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proceedings of the National Academy of Sciences of the United States of America, 94 (21), 11514-11519. doi: 10.1073/pnas.94.21.11514
Expression of a recombinant single chain Fv antibody fragment in mammalian cells
Chotigeat, Wilaiwan and Mahler, Stephen M. (1997). Expression of a recombinant single chain Fv antibody fragment in mammalian cells. Journal of the Science Society of Thailand, 23 (3), 159-170. doi: 10.2306/scienceasia1513-1874.1997.23.159
Mahler, SM, Marquis, CP, Brown, G, Roberts, A and Hoogenboom, HR (1997). Cloning and expression of human V-genes derived from phage display libraries as fully assembled human anti-TNF alpha monoclonal antibodies. Immunotechnology, 3 (1), 31-43. doi: 10.1016/S1380-2933(96)00058-9
A Master's program in biopharmaceutical science
Neering, IR, Fryer, MW and Mahler, SM (1996). A Master's program in biopharmaceutical science. Australasian Biotechnology, 6 (5), 272-276.
Chin, C. K., Schofield, P. R., Robertson, D. M., Gray, P. P., Chotigeat, W. and Mahler, S. M. (1996). Biological activity and metabolic clearance of recombinant human follicle stimulating hormone produced in Sp2/0 myeloma cells. Cytotechnology, 21 (2), 171-182. doi: 10.1007/BF02215667
Jespers, LS, Roberts, A, Mahler, SM, Winter, G and Hoogenboom, HR (1994). Guiding the Selection of Human-Antibodies From Phage Display Repertoires to a Single Epitope of An Antigen. Bio-Technology, 12 (9), 899-903. doi: 10.1038/nbt0994-899
Chotigeat, W., Watanapokasin, Y., Mahler, S. M. and Gray, P. P. (1994). Role of environmental conditions on the expression levels, glycoform pattern and levels of sialyltransferase enzymes for hFSH produced by recombinant CHO cells. Cytotechnology, 15 (1-3), 217-221. doi: 10.1007/BF00762396
Cerpapoljak, A, Bishop, LA, Hort, YJ, Chin, Ckh, Dekroon, R, Mahler, SM, Smith, GM, Stuart, MC and Schofield, PR (1993). Isoelectric Charge of Recombinant Human Follicle-Stimulating-Hormone Isoforms Determines Receptor Affinity and Invitro Bioactivity. Endocrinology, 132 (1), 351-356. doi: 10.1210/en.132.1.351
Mammalian cell culture at the University of New South Wales
Gray, P. P., Marsden, W. L., Crowley, J., Gebert, C., Jirasripongpun, K., Lovrecz, G., Mitchell, C. and Mahler, S. M. (1990). Mammalian cell culture at the University of New South Wales. Australian Journal of Biotechnology, 4 (2), 121-134.
Downstream processing of monoclonal antibodies
Gunnersen, J. M., Fowles, L. F., Snelgar, J. M., Mitchell, C. A., Patava, J. V., Osborne, K. J. and Mahler, S. M. (1989). Downstream processing of monoclonal antibodies. Australian Journal of Biotechnology, 3 (1), 69-71.
Mahler, SM and Wilce, PA (1988). Desensitization of Adenylate-Cyclase and Cyclic-Amp Flux During the Early Stages of Liver-Regeneration. Journal of Cellular Physiology, 136 (1), 88-94. doi: 10.1002/jcp.1041360111
Studies On Regenerating Liver and Hepatoma Plasma-Membranes .1. Lipid and Protein-Composition
Mahler, SM, Wilce, PA and Shanley, BC (1988). Studies On Regenerating Liver and Hepatoma Plasma-Membranes .1. Lipid and Protein-Composition. International Journal of Biochemistry, 20 (6), 605-&. doi: 10.1016/0020-711X(88)90100-0
Mahler, SM, Wilce, PA and Shanley, BC (1988). Studies On Regenerating Liver and Hepatoma Plasma-Membranes .2. Membrane Fluidity and Enzyme-Activity. International Journal of Biochemistry, 20 (6), 613-619. doi: 10.1016/0020-711X(88)90101-2
Canine PET/CT imaging with 64Cu-nanomedicines
Daniel, Sarah, Houston, Zachary, Fletcher, Nicholas, Bell, Craig, Atcheson, Nicole, Al-Najjar, Aiman, Howard, Christopher, Mahler, Stephen, Straw, Rod and Thurecht, Kristofer (2020). Canine PET/CT imaging with 64Cu-nanomedicines. SNMMI Annual Meeting, Online, 11-14 July, 2020. Reston, VA, United States: Society of Nuclear Medicine.
Ekman, Serena, Flower, Robert, Hyland, Catherine, Mahler, Stephen, Jones, Martina and Bui, Xuan (2019). Identification of novel monoclonal antibodies recognising JENU and U antigens of the MNS blood group system. Pathology Update 2019, Melbourne, VIC Australia, 22- 24 February 2019. London, United Kingdom: Lippincott Williams & Wilkins. doi: 10.1016/j.pathol.2018.12.353
In silico model for glycophorin a (GPA) structure
Ekman, Serena, Flower, Robert, Hyland, Catherine, Mahler, Stephen, Jones, Martina, Treutlein, Herbert and Bui, Xuan (2019). In silico model for glycophorin a (GPA) structure. Pathology Update 2019, Melbourne, VIC Australia, 22- 24 February 2019. London, United Kingdom: Lippincott Williams & Wilkins. doi: 10.1016/j.pathol.2018.12.352
In silico modelling of glycophorin MNS system blood group antigens
Flower, R., Ekman, S., Mahler, S., Jones, M., Malde, A. K. and Bui, X. (2019). In silico modelling of glycophorin MNS system blood group antigens. In: ANZSBT, Perth, Australia, (24-25). 20-23 October 2019.
Innovation in diagnosis and treatment of brain metastases using multifunctional nanomedicines
Saunus, J. M., Lim, M., Puttick, S., Croft, P. Kalita-de, Houston, Z. H., Jones, M. L., Latter, M. J., Campbell, L. C., Thomas, P., Jeffree, R. L., Rose, S. E., Mahler, S. M., Thurecht, K. J., Scott, A. M. and Lakhani, S. R. (2019). Innovation in diagnosis and treatment of brain metastases using multifunctional nanomedicines. San Antonio Breast Cancer Symposium, San Antonio, Texas, 4-8 December 2018. Philadelphia, PA, United States: American Association for Cancer Research. doi: 10.1158/1538-7445.SABCS18-P1-19-02
CD83 Expression On Human Immune Cells as a Target for Immunosuppression
Hart, D. N. J., Elgundi, Z., Ju Xinsheng, Verma, N. D., Silveira, P. A., Fromm, P. D., Alingcastre, R., Munster, D. J., Seldon, T. A., Sheng, Y., Jones, M. L., Munro, T. P., Mahler, S., Barnard, R. T., Vu, P. A., Lo, K., Shahin, K., Larsen, S., Bradstock, K. and Clark, G. J. (2015). CD83 Expression On Human Immune Cells as a Target for Immunosuppression. 33rd Annual Scientific Meeting of the Transplantation Society of Australia and new Zealand, Canberra, ACT Australia, 21-23 June 2015. London, United Kingdom: Nature Publishing Group. doi: 10.1038/icb.2015.75
Hart, Derek N. J., Ju, Xinsheng, Elgundi, Zehra, Verma, Nirupama, Silveira, Pablo, Fromm, Phillip, Alingcastre, Renz, Hsu, Blake, Munster, David J., Seldon, Therese, Sheng, Yonghua, Jones, Martina, Munro, Trent, Mahler, Stephen, Barnard, Ross, Vu, Al, Lo, Tsun Ho, Shahin, Kifah, Larsen, Stephen Robert, Bradstock, Kenneth and Clark, Georgina (2015). Characterisation of human CD83 expression on immune cells and their targeting with CD83 antibodies to prevent graft versus host disease in allogeneic haematopoietic cell transplantation. 57th Annual Meeting of the American Society of Hematology, Orlando, FL, United States, 5-8 Dec 2015. WASHINGTON: AMER SOC HEMATOLOGY.
Ju, Xinsheng, Elgundi, Zehra, Verma, Nirupama, Silveira, Pablo, Fromm, Phillip, Alingcastre, Renz, Munster, David, Seldon, Therese, Sheng, Yonghua, Jones, Martina, Munro, Trent, Mahler, Stephen, Barnard, Ross, Vu, Ai, Lo, Tsun Ho, Shahin, Kifah, Clark, Georgina, Larsen, Stephen, Bradstock, Kenneth and Hart, Derek (2015). Human Cd83 Expression On Immune Cells Validates Anti-Cd83 Prophylaxis to Prevent Graft Versus Host Disease in Allogeneic Haematopoietic Cell Transplantation.. 14th Transplantation Science Symposium of the Transplantation-Society (TSS), Lorne, Australia, 11-13 November 2015. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.
Verma, Nirupama D., Munster, David, Seldon, Therese, Sheng, Yong Hua, Jones, Martina, Munro, Trent, Mahler, Stephen, Barnard, Ross, Vu, Phi Ai, Lo, Kevin, Shahin, Kifah, Elgundi, Zehra, Silveira, Pablo, Fromm, Phillip D., Clark, Georgina J., Larsen, Stephen, Bradstock, Kenneth and Hart, Derek N. J. (2015). The Human Monoclonal Antibody 3C12C, Targeting Activated Dendritic Cells Is a Potential New Immunosuppressive Agent. BMT Tandem Meetings, San Diego, CA United States, 11-15 February 2015. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.bbmt.2014.11.527
Hart, D, Verma, N., Seldon, T, Sheng, Y., Pryor, R., Palkova, A., Findova, M., Jones, M., Munro, T., Mahler, S., Braet, K., Barnard, R., Marks, J., Coley, A., Fan, F., Zhou, Y., Vu, P, Lo, K., Shahin, K., Elgundi, Z., Silveira, P., Fromm, P., Clark, G., Larsen, S., Bradstock, K. and Munster, D. (2014). The Monoclonal Antibody 3C12C, Targeting CD83 Is a T Cell Sparing, Potential New Immunosuppressive Agent. 2014 World Transplant Congress, San Francicso Ca, 26 - 31 July 2014. Malden, MA United States: Wiley-Blackwell Publishing, Inc.. doi: 10.1111/ajt.12888
Developing a Therapeutic Anti - Dendritic Cell Antibody to Prevent Graft Versus Host Disease
Hart, D, Seldon, T, Jones, M, Sheng, Y, Palkova, A, Cullup, H, Munro, T, Sinfield, L, Rice, AM, Wilson, J, Gray, P, Barnard, R, Mahler, S and Munster, D (2009). Developing a Therapeutic Anti - Dendritic Cell Antibody to Prevent Graft Versus Host Disease. 51st Annual Meeting of the American Society of Hematology, New Orleans LA, 5-8 December 2009. Washington, D.C.: American Society of Hematology.
Vari, F., Rossetti, T., Prue, R., Mahler, S. and Hart, D.N. (2006). A CMRF-56 blood dendritic cell preparation loaded with control and tumour-associated antigens, for the immune therapy of multiple myeloma: Transition to a phase I clinical trial. x, x, x. United Kingdom: Informa Healthcare.
Marcal, H, Raftery, M, Sarris, M, Mcfarland, C, Milthorpe, BK, Bhasin, V, Mackay-Sim, A and Mahler, S (2006). Secretome analysis of olfactory ensheathing cells for use in tissue engineering and regenerative medicine applications. Unknown, unknown, Unknown. BETHESDA: AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC.
Human-Antibodies Derived From Rodent Antibodies Via Epitope Imprinted Selection (eis)
Hoogenboom, HR, Jespers, L, Mahler, S, Roberts, AJ, Chiswell, DJ and Winter, G (1994). Human-Antibodies Derived From Rodent Antibodies Via Epitope Imprinted Selection (eis). NEW YORK: WILEY-LISS.
Chotigeat, W, Watanapokasin, Y, Mahler, S and Gray, PP (1994). Role of Environmental-Conditions On the Expression Levels, Glycoform Pattern and Levels of Sialyltransferase for Hfsh Produced by Recombinant Cho Cells. Cell Culture Engineering IV Conference, San Diego Ca, Mar 07-12, 1994. DORDRECHT: SPRINGER. doi: 10.1007/BF00762396
Comparative-Studies On Plasma-Membrane Isolated From Liver, Hepatoma and Regenerating Liver
Mahler, S, Wilce, PA and Shanley, BC (1986). Comparative-Studies On Plasma-Membrane Isolated From Liver, Hepatoma and Regenerating Liver. BALGOWLAH: ADIS PRESS AUSTRALASIA P/L.
Membrane Fluidity in Rat Hepatoma Plasma-Membranes
Mahler, S, Shanley, BC and Wilce, PA (1984). Membrane Fluidity in Rat Hepatoma Plasma-Membranes. CLAYTON: PROC AUST BIOCHEMICAL SOC.
Anti-CD83 antibodies and use thereof
Seldon, T. A., Munster, D. J., Hart, D. N., Jones, M. L., Munro, T. P., Mahler, S. M., Zhou, Y. and Marks, D. (2013). Anti-CD83 antibodies and use thereof.
Isolation method for recombinant glycoprotein biopharmaceuticals
Catzel, D., Gray, P. P. and Mahler, S. M. (2003). Isolation method for recombinant glycoprotein biopharmaceuticals. Australian Provisional Patent #61759780.
Compositions for protein delivery via the pulmonary route
Mahler, S. M., Waters, M., Chan, H. K. and Goodall, S. (2001). Compositions for protein delivery via the pulmonary route.
Process for production of glycoproteins
Mahler, S. M., Gebert, C., Chotigeat, W. and Gray, P. P. (1996). Process for production of glycoproteins.
A system for expression of recombinant proteins
Rajkovic, I., Chin, C. K. and Mahler, S. M. (1996). A system for expression of recombinant proteins. PM4219.
ACRF Facility for Targeted Radiometals in Cancer (AFTRiC)
(2021–2023) Australian Cancer Research Foundation
An integrated, multi-node bio-layer interferometry facility
(2020–2021) ARC Linkage Infrastructure, Equipment and Facilities
Smart affinity membranes for manufacture of high value therapeutic proteins
(2019–2022) ARC Linkage Projects
Nanomedicine strategies for early detection and treatment of brain metastases
(2019–2021) NHMRC Project Grant
(2019) UQ Major Equipment and Infrastructure
(2019) UQ Major Equipment and Infrastructure
Cyto-Mine to accelerate Cell Line Development for Vaccines and Biopharmaceuticals
(2019) UQ Major Equipment and Infrastructure
Continuous chromatography system for advanced bioprocessing
(2018) UQ Major Equipment and Infrastructure
In vivo optical imaging into the next generation
(2018) UQ Research Facilities Infrastructure Grants
ARC Training Centre for Biopharmaceutical Innovation
(2017–2023) ARC Industrial Transformation Training Centres
Affinity Maturation of Anti-Lipopolysaccharide Antibody
(2017–2018) Innovation Connections
Provision of research services to Minomic International Ltd
(2017–2018) Minomic International Ltd
Next generation hybrid nanomaterials: bispecific antibody-targeted polymers
(2016–2019) ARC Linkage Projects
Immuno-polymeric drugs for prostate cancer therapy
(2016–2018) NHMRC Project Grant
EGFR targeted nanoparticle feasibility study
(2016–2017) Samyang Biopharmaceuticals Corporation
(2016–2017) Research Connections
Exosome and Bio/Nanoparticle Characterisation Facility
(2016) UQ Major Equipment and Infrastructure
Developing targeted EphA2 based imaging technology for glioblastoma
(2015–2016) Cure Brain Cancer Foundation
(2015) UQ Major Equipment and Infrastructure
(2014–2023) Therapeutic Innovation Australia Limited
Safety assessment of anti-hendra virus antibody in humans
(2013–2015) Queensland Health
(2013) UniQuest Pty Ltd
Single molecule spectroscopy-guided design of thermostable industrial enzymes
(2012–2015) ARC Linkage Projects
(2012–2015) ARC Linkage Projects
(2012–2015) ARC Linkage Projects
Safety of Hendra virus anti-G glycoprotein monoclonal antibody in humans
(2012–2013) NHMRC Targeted Research
Mass spectrometer for biomolecule discovery, structural analysis and quantification.
(2011) UQ Major Equipment and Infrastructure
(2010–2013) ARC Linkage Projects
(2010–2012) UQ Collaboration and Industry Engagement Fund
High throughput isolation and expression of recombinant antibodies in mammalian cells
(2010–2011) UQ FirstLink Scheme
(2010) UQ Major Equipment and Infrastructure
(2009) UQ Faculty Co-Funding
Stem cell-based interface tissue engineering
(2009) ARC Discovery Projects
Engineering Novel Theranostics for High Grade Glioma Through Site-Specific EphA2 Antibody Modification
Doctor Philosophy — Associate Advisor
Other advisors:
Development of Antibody Delivery Systems Against Intracellular Targets
Doctor Philosophy — Associate Advisor
Other advisors:
From Target Discovery to Therapeutic Antibodies
Doctor Philosophy — Associate Advisor
Other advisors:
Biosimilar litigation and market entry
Doctor Philosophy — Associate Advisor
Other advisors:
Characterising murine red blood cell phenotypes: the impact of genetic variants in Klf1 and Casd1
(2021) Doctor Philosophy — Principal Advisor
Other advisors:
(2020) Doctor Philosophy — Principal Advisor
Other advisors:
(2019) Doctor Philosophy — Principal Advisor
Other advisors:
Isolation and development of antibodies for active targeting of nanocells for cancer therapy
(2018) Doctor Philosophy — Principal Advisor
Other advisors:
Development and Application of Novel Biosensor Technologies
(2017) Doctor Philosophy — Principal Advisor
Other advisors:
Development of anti-PEG bispecific antibodies for targeting PEGylated nanoparticles to tumour cells
(2017) Master Philosophy — Principal Advisor
Other advisors:
Antibody Discovery for Development of a Serotyping Dengue Virus NS1 Capture Assay
(2015) Doctor Philosophy — Principal Advisor
Other advisors:
Beyond antibodies: development of a novel molecular scaffold based on human Chaperonin 10
(2015) Doctor Philosophy — Principal Advisor
(2015) Doctor Philosophy — Principal Advisor
Other advisors:
(2015) Doctor Philosophy — Principal Advisor
Other advisors:
(2023) Doctor Philosophy — Associate Advisor
Other advisors:
Development of monoclonal antibodies against human neutrophil antigen 3 (HNA-3)
(2022) Doctor Philosophy — Associate Advisor
Other advisors:
(2022) Doctor Philosophy — Associate Advisor
Other advisors:
(2022) Doctor Philosophy — Associate Advisor
Other advisors:
(2021) Doctor Philosophy — Associate Advisor
Other advisors:
Structural Studies of MNS Glycophorins to Guide the Discovery of Monoclonal Antibodies
(2021) Doctor Philosophy — Associate Advisor
Other advisors:
(2021) Doctor Philosophy — Associate Advisor
Other advisors:
Development of novel bioconjugation strategies for creating cancer-targeting nanomaterials
(2020) Doctor Philosophy — Associate Advisor
Other advisors:
(2018) Doctor Philosophy — Associate Advisor
Other advisors:
Development of monoclonal antibodies as tools for analysis of PTPRJ function.
(2015) Doctor Philosophy — Associate Advisor
Other advisors:
Surface interactions and biochemical responses to bacterial attachment in bioleaching of minerals
(2014) Doctor Philosophy — Associate Advisor
Other advisors: